Basal cell carcinoma natural history: Difference between revisions
Created page with "{{Basal cell carcinoma}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{Epithelial neoplasms}} {{Diseases of the skin and appendages by morphology}} {{Tumors of bone, c..." |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Basal cell carcinoma}} | {{Basal cell carcinoma}} | ||
{{CMG}} | {{CMG}} | ||
== | |||
==Prognosis== | |||
Although basal cell carcinoma rarely [[metastasis|metastasizes]], it grows locally with invasion and destruction of local tissues, without stopping. The cancer can impinge on vital structures and result in loss of extension or loss of function or rarely [[death]]. The vast majority of cases can be successfully treated before serious complications occur. The recurrence rate for the above treatment options ranges from 50% to 1% or less. | |||
In choosing the therapy, one must weigh the benefit gained from the morbidity of the procedure. As most basal cell carcinomas are slow growing, and not deadly; the health and age of the patient must be considered. Although difficult to discuss, radiation therapy, topical chemotherapy, or no treatment at all should be considered in ill or frail individuals in difficult to excise tumor of no immediate harm to the individual. While methods with the highest cure rate should be considered for young and healthy individuals with long life expectancy. It is here that one should seriously consider the cure rate of [[Mohs surgery]] vs. standard excision by a plastic surgeon vs. radiation therapy. | |||
==References== | ==References== | ||
Revision as of 18:43, 19 January 2012
|
Basal cell carcinoma Microchapters |
|
Diagnosis |
|---|
|
Case Studies |
|
Basal cell carcinoma natural history On the Web |
|
American Roentgen Ray Society Images of Basal cell carcinoma natural history |
|
Risk calculators and risk factors for Basal cell carcinoma natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Prognosis
Although basal cell carcinoma rarely metastasizes, it grows locally with invasion and destruction of local tissues, without stopping. The cancer can impinge on vital structures and result in loss of extension or loss of function or rarely death. The vast majority of cases can be successfully treated before serious complications occur. The recurrence rate for the above treatment options ranges from 50% to 1% or less.
In choosing the therapy, one must weigh the benefit gained from the morbidity of the procedure. As most basal cell carcinomas are slow growing, and not deadly; the health and age of the patient must be considered. Although difficult to discuss, radiation therapy, topical chemotherapy, or no treatment at all should be considered in ill or frail individuals in difficult to excise tumor of no immediate harm to the individual. While methods with the highest cure rate should be considered for young and healthy individuals with long life expectancy. It is here that one should seriously consider the cure rate of Mohs surgery vs. standard excision by a plastic surgeon vs. radiation therapy.
References
Template:Tumors of bone, cartilage, skin, connective, and soft tissue
Template:SIB
de:Basaliom
nl:Basaalcelcarcinoom
fi:Basaliooma